CC-001 (Change Cure)

N/A

Report date: 2025/12/10 10:17:06

Base Information

Drug NameCC-001 (Change Cure)
Drug Alias NameCC001CC-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHigh Mobility Group Protein B1 modulators
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute of Science TokyoChange Cure
China Registration ClassN/A

Develop Information

Active CompaniesChange Cure
Inactive CompaniesN/A
Active IndicationsFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A